WW INTERNATIONAL, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that WW INTERNATIONAL, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 30, 2017 | $312.49M | Feb 28, 2018 |
| FY2017 | Sep 30, 2017 | $323.69M | Feb 28, 2018 |
| FY2017 | Jul 1, 2017 | $341.67M | Feb 28, 2018 |
| FY2017 | Apr 1, 2017 | $329.06M | Feb 28, 2018 |
| FY2017 | Dec 31, 2016 | $267.41M | Feb 28, 2018 |
| FY2017 | Oct 1, 2016 | $280.82M | Feb 28, 2018 |
| FY2017 | Jul 2, 2016 | $309.76M | Feb 28, 2018 |
| FY2017 | Apr 2, 2016 | $306.91M | Feb 28, 2018 |
| FY2016 | Jan 2, 2016 | $259.24M | Mar 1, 2017 |
| FY2016 | Oct 3, 2015 | $273.32M | Mar 1, 2017 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $347.07M | Mar 16, 2026 |
| FY2025 | Jun 24, 2025 | $363.57M | Mar 16, 2026 |
| FY2025 | Dec 28, 2024 | $785.92M | Mar 16, 2026 |
| FY2023 | Dec 30, 2023 | $205.96M | Feb 28, 2024 |
| FY2023 | Sep 30, 2023 | $214.87M | Feb 28, 2024 |
| FY2023 | Jul 1, 2023 | $226.83M | Feb 28, 2024 |
| FY2023 | Apr 1, 2023 | $241.90M | Feb 28, 2024 |
| FY2023 | Dec 31, 2022 | $222.90M | Feb 28, 2024 |
| FY2023 | Oct 1, 2022 | $249.72M | Feb 28, 2024 |
| FY2023 | Jul 2, 2022 | $269.45M | Feb 28, 2024 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $247.12M | Mar 16, 2026 |
| FY2025 | Jun 24, 2025 | $263.38M | Mar 16, 2026 |
| FY2025 | Dec 28, 2024 | $533.10M | Mar 16, 2026 |
| FY2023 | Dec 30, 2023 | $124.86M | Feb 28, 2024 |
| FY2023 | Sep 30, 2023 | $141.76M | Feb 28, 2024 |
| FY2023 | Jul 1, 2023 | $143.18M | Feb 28, 2024 |
| FY2023 | Apr 1, 2023 | $119.51M | Feb 28, 2024 |
| FY2023 | Dec 31, 2022 | $125.97M | Feb 28, 2024 |
| FY2023 | Oct 1, 2022 | $152.35M | Feb 28, 2024 |
| FY2023 | Jul 2, 2022 | $162.96M | Feb 28, 2024 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($62.10M) | Mar 16, 2026 |
| FY2025 | Jun 24, 2025 | $1.12B | Mar 16, 2026 |
| FY2025 | Dec 28, 2024 | ($345.70M) | Mar 16, 2026 |
| FY2023 | Dec 30, 2023 | ($88.14M) | Feb 28, 2024 |
| FY2023 | Sep 30, 2023 | $43.73M | Feb 28, 2024 |
| FY2023 | Jul 1, 2023 | $50.83M | Feb 28, 2024 |
| FY2023 | Apr 1, 2023 | ($118.68M) | Feb 28, 2024 |
| FY2023 | Dec 31, 2022 | ($35.78M) | Feb 28, 2024 |
| FY2023 | Oct 1, 2022 | ($206.04M) | Feb 28, 2024 |
| FY2023 | Jul 2, 2022 | ($6.80M) | Feb 28, 2024 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($2.32M) | Mar 16, 2026 |
| FY2025 | Jun 24, 2025 | $21.20M | Mar 16, 2026 |
| FY2025 | Dec 28, 2024 | ($236.22M) | Mar 16, 2026 |
| FY2023 | Dec 30, 2023 | ($6.01M) | Feb 28, 2024 |
| FY2023 | Sep 30, 2023 | $30.61M | Feb 28, 2024 |
| FY2023 | Jul 1, 2023 | $26.32M | Feb 28, 2024 |
| FY2023 | Apr 1, 2023 | ($28.58M) | Feb 28, 2024 |
| FY2023 | Dec 31, 2022 | ($51.78M) | Feb 28, 2024 |
| FY2023 | Oct 1, 2022 | ($254.53M) | Feb 28, 2024 |
| FY2023 | Jul 2, 2022 | $13.37M | Feb 28, 2024 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $115.66M | Mar 16, 2026 |
| FY2025 | Jun 24, 2025 | $78.48M | Mar 16, 2026 |
| FY2025 | Dec 28, 2024 | $175.67M | Mar 16, 2026 |
| FY2025 | Dec 30, 2023 | $217.56M | Mar 16, 2026 |
| FY2024 | Dec 31, 2022 | $263.84M | Feb 28, 2025 |
| FY2023 | Jan 1, 2022 | $268.61M | Feb 28, 2024 |
| FY2022 | Jan 2, 2021 | $297.29M | Mar 6, 2023 |
| FY2021 | Dec 28, 2019 | $254.70M | Mar 1, 2022 |
| FY2020 | Dec 29, 2018 | $251.11M | Mar 30, 2021 |
| FY2019 | Dec 30, 2017 | $211.22M | Feb 25, 2020 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.53M | Mar 16, 2026 |
| FY2025 | Jun 24, 2025 | ($34.42M) | Mar 16, 2026 |
| FY2025 | Dec 28, 2024 | ($16.84M) | Mar 16, 2026 |
| FY2025 | Dec 30, 2023 | $6.69M | Mar 16, 2026 |
| FY2024 | Dec 31, 2022 | $76.65M | Feb 28, 2025 |
| FY2023 | Jan 1, 2022 | $157.28M | Feb 28, 2024 |
| FY2022 | Jan 2, 2021 | $135.94M | Mar 6, 2023 |
| FY2021 | Dec 28, 2019 | $182.38M | Mar 1, 2022 |
| FY2020 | Dec 29, 2018 | $295.59M | Mar 30, 2021 |
| FY2019 | Dec 30, 2017 | $222.27M | Feb 25, 2020 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 24, 2025 | $87.0K | Mar 16, 2026 |
| FY2025 | Dec 28, 2024 | $718.0K | Mar 16, 2026 |
| FY2025 | Dec 30, 2023 | $2.49M | Mar 16, 2026 |
| FY2024 | Dec 31, 2022 | $2.07M | Feb 28, 2025 |
| FY2023 | Jan 1, 2022 | $2.45M | Feb 28, 2024 |
| FY2022 | Jan 2, 2021 | $21.49M | Mar 6, 2023 |
| FY2021 | Dec 28, 2019 | $17.16M | Mar 1, 2022 |
| FY2020 | Dec 29, 2018 | $19.05M | Mar 30, 2021 |
| FY2019 | Dec 30, 2017 | $13.73M | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $5.56M | Feb 26, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $946.76M | Mar 16, 2026 |
| FY2025 | Jun 24, 2025 | $1.02B | Mar 16, 2026 |
| FY2025 | Dec 28, 2024 | $550.28M | Mar 16, 2026 |
| FY2024 | Dec 30, 2023 | $982.03M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $1.03B | Feb 28, 2024 |
| FY2022 | Jan 1, 2022 | $1.43B | Mar 6, 2023 |
| FY2021 | Jan 2, 2021 | $1.48B | Mar 1, 2022 |
| FY2020 | Dec 28, 2019 | $1.50B | Mar 30, 2021 |
| FY2019 | Dec 29, 2018 | $1.41B | Feb 25, 2020 |
| FY2018 | Dec 30, 2017 | $1.25B | Feb 26, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $628.69M | Mar 16, 2026 |
| FY2025 | Jun 24, 2025 | $645.02M | Mar 16, 2026 |
| FY2025 | Dec 28, 2024 | $1.66B | Mar 16, 2026 |
| FY2024 | Dec 30, 2023 | $1.74B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $1.71B | Feb 28, 2024 |
| FY2022 | Jan 1, 2022 | $1.89B | Mar 6, 2023 |
| FY2021 | Jan 2, 2021 | $2.03B | Mar 1, 2022 |
| FY2020 | Dec 28, 2019 | $2.18B | Mar 30, 2021 |
| FY2019 | Dec 29, 2018 | $2.22B | Feb 25, 2020 |
| FY2018 | Dec 30, 2017 | $2.26B | Feb 26, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $318.07M | Mar 16, 2026 |
| FY2025 | Jun 24, 2025 | $378.53M | Mar 16, 2026 |
| FY2025 | Dec 28, 2024 | ($1.11B) | Mar 16, 2026 |
| FY2025 | Dec 30, 2023 | ($761.09M) | Mar 16, 2026 |
| FY2025 | Dec 31, 2022 | ($685.78M) | Mar 16, 2026 |
| FY2024 | Jan 1, 2022 | ($452.90M) | Feb 28, 2025 |
| FY2021 | Jan 2, 2021 | ($548.21M) | Mar 1, 2022 |
| FY2020 | Dec 28, 2019 | ($685.54M) | Mar 30, 2021 |
| FY2019 | Dec 29, 2018 | ($808.94M) | Feb 25, 2020 |
| FY2018 | Dec 30, 2017 | ($1.02B) | Feb 26, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $200.14M | Mar 16, 2026 |
| FY2025 | Jun 25, 2025 | $199.05M | Mar 16, 2026 |
| FY2025 | Jun 24, 2025 | $199.05M | Mar 16, 2026 |
| FY2025 | Dec 28, 2024 | $239.58M | Mar 16, 2026 |
| FY2025 | Dec 30, 2023 | $243.44M | Mar 16, 2026 |
| FY2024 | Dec 31, 2022 | $156.00M | Feb 28, 2025 |
| FY2023 | Jan 1, 2022 | $157.37M | Feb 28, 2024 |
| FY2022 | Jan 2, 2021 | $155.62M | Mar 6, 2023 |
| FY2021 | Dec 28, 2019 | $157.92M | Mar 1, 2022 |
| FY2019 | Dec 29, 2018 | $152.52M | Feb 25, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($62.10M) | Mar 16, 2026 |
| FY2025 | Dec 28, 2024 | $1.94B | Mar 16, 2026 |
| FY2024 | Dec 30, 2023 | $2.31B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $2.42B | Feb 28, 2024 |
| FY2022 | Jan 1, 2022 | $2.68B | Mar 6, 2023 |
| FY2021 | Jan 2, 2021 | $2.62B | Mar 1, 2022 |
| FY2020 | Dec 28, 2019 | $2.50B | Mar 30, 2021 |
| FY2019 | Dec 29, 2018 | $2.38B | Feb 25, 2020 |
| FY2018 | Dec 30, 2017 | $2.20B | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $2.06B | Feb 28, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $160.28M | Mar 16, 2026 |
| FY2025 | Jun 24, 2025 | $140.59M | Mar 16, 2026 |
| FY2025 | Dec 28, 2024 | $53.02M | Mar 16, 2026 |
| FY2024 | Dec 30, 2023 | $109.37M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $178.33M | Feb 28, 2024 |
| FY2022 | Jan 1, 2022 | $153.79M | Mar 6, 2023 |
| FY2021 | Jan 2, 2021 | $165.89M | Mar 1, 2022 |
| FY2020 | Dec 28, 2019 | $182.74M | Mar 30, 2021 |
| FY2019 | Dec 29, 2018 | $236.97M | Feb 25, 2020 |
| FY2018 | Dec 30, 2017 | $83.05M | Feb 26, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 28, 2024 | $1.43B | Feb 28, 2025 |
| FY2024 | Dec 30, 2023 | $1.43B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $1.42B | Feb 28, 2024 |
| FY2022 | Jan 1, 2022 | $1.42B | Mar 6, 2023 |
| FY2021 | Jan 2, 2021 | $1.49B | Mar 1, 2022 |
| FY2019 | Dec 28, 2019 | $1.61B | Feb 25, 2020 |
| FY2018 | Dec 29, 2018 | $1.78B | Feb 26, 2019 |
| FY2017 | Dec 30, 2017 | $1.87B | Feb 28, 2018 |
| FY2017 | Dec 31, 2016 | $2.02B | Feb 28, 2018 |
| FY2016 | Jan 2, 2016 | $2.23B | Mar 1, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (6) | Mar 16, 2026 |
| FY2025 | Jun 24, 2025 | 13 | Mar 16, 2026 |
| FY2025 | Dec 28, 2024 | (4) | Mar 16, 2026 |
| FY2023 | Dec 30, 2023 | (1) | Feb 28, 2024 |
| FY2023 | Sep 30, 2023 | 0 | Feb 28, 2024 |
| FY2023 | Jul 1, 2023 | 0 | Feb 28, 2024 |
| FY2023 | Apr 1, 2023 | (1) | Feb 28, 2024 |
| FY2023 | Dec 31, 2022 | 0 | Feb 28, 2024 |
| FY2023 | Oct 1, 2022 | (2) | Feb 28, 2024 |
| FY2023 | Jul 2, 2022 | 0 | Feb 28, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (6) | Mar 16, 2026 |
| FY2025 | Jun 24, 2025 | 13 | Mar 16, 2026 |
| FY2025 | Dec 28, 2024 | (4) | Mar 16, 2026 |
| FY2023 | Dec 30, 2023 | (1) | Feb 28, 2024 |
| FY2023 | Sep 30, 2023 | 0 | Feb 28, 2024 |
| FY2023 | Jul 1, 2023 | 0 | Feb 28, 2024 |
| FY2023 | Apr 1, 2023 | (1) | Feb 28, 2024 |
| FY2023 | Dec 31, 2022 | 0 | Feb 28, 2024 |
| FY2023 | Oct 1, 2022 | (2) | Feb 28, 2024 |
| FY2023 | Jul 2, 2022 | 0 | Feb 28, 2024 |